Signal active
Organization
Contact Information
Overview
LakePharma is a contract research organization (CRO) specializing in antibody and protein engineering, cell line development, and protein production. The company's range of services covering areas such as antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing and bioanalytics focus on integrated platforms to support projects throughout the drug discovery process and offers dedicated client services and sophisticated software to provide real-time access to project data via a secure cloud-based portal enabling clients to accelerate product development from lead discovery to Phase 1 clinical trials.
Located in the heart of the San Francisco Bay Area, LakePharma has developed numerous in-house technology platforms to provide cost-effective and high quality services to its customers. The production processes are SOP-based and high-throughput, and have been streamlined to be exceptionally efficient on both a small and large scale. Each project is actively managed by a dedicated study director to ensure timely completion with superior results and transparent communication. Clients have real-time access to their project data and can view and receive status updates through LakePharma’s secure cloud-based Datasystems. LakePharma follows the principles of Good Laboratory Practices (GLP) to ensure the quality, reliability and integrity of study data. Upon request, services can also be performed in full compliance with FDA documentation requirements for submissions for nonclinical laboratory studies. All services are provided solely on a fee-for-service basis and are royalty-free.
About
Biotechnology, Life Science, Health Care, Pharmaceutical
2009
101-250
Headquarters locations
Belmont, California, United States, North America
Social
Profile Resume
LakePharma headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care, Pharmaceutical sector. The company focuses on Biotechnology and has secured $480.0M in funding across 16 round(s). With a team of 101-250 employees, LakePharma is actively contributing to advancements in Biotechnology. Their latest funding round, Private Equity Round - LakePharma, raised $30.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
1
2
0
$30.0M
Details
1
LakePharma has raised a total of $30.0M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2017 | Private Equity | 30.0M |
Investors
LakePharma is funded by 6 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Summit Partners | - | FUNDING ROUND - Summit Partners | 30.0M |
Eric B. Lev | - | FUNDING ROUND - Eric B. Lev | 30.0M |
LakePharma | - | FUNDING ROUND - LakePharma | 30.0M |
Ampersand Capital Partners | - | FUNDING ROUND - Ampersand Capital Partners | 30.0M |
Recent Activity
News
Jan 11, 2024
Artrocker - GMP Plasmid DNA Market Size, Predicting Trends and Growth ...
News
Aug 30, 2023
Yahoo Finance - Conjugation and Labeling Services Industry Outlook to 2035 ...
News
Nov 04, 2021
Google Patent - Compositions for inducing protective immune response against sars-cov-2 …
Funding Round
Dec 12, 2017
LakePharma raised $30000000 on 2017-12-12 in Private Equity Round